Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
16.53
+2.71 (19.61%)
At close: Jun 22, 2026, 4:00 PM EDT
16.06
-0.47 (-2.84%)
After-hours: Jun 22, 2026, 5:40 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $438.47 million as of June 22, 2026. Its market cap has increased by 63.64% in one year.
Market Cap
438.47M
Enterprise Value
413.34M
1-Year Change
63.64%
Ranking
Category
Stock Price
$16.53
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $438.47M, an increase of 655.90%. That is a compound annual growth rate of 58.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 438.47M | 126.72% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 370.98M |
| Rocket Pharmaceuticals | 369.62M |
| Verastem | 366.43M |
| Silence Therapeutics | 364.65M |
| Upstream Bio | 356.45M |
| Greenwich LifeSciences | 355.65M |
| Vanda Pharmaceuticals | 354.80M |
| Atea Pharmaceuticals | 352.92M |